HDAC3 and breast cancer: Other studies in HR-positive breast cancer demonstrate that HDAC1 and HDAC3 are recruited to the PS2 and c-MYC promoters in a tamoxifen-dependent manner as part of chromatin-remodeling complexes: HDAC3-containing NCoR and HDAC1-containing NuRD [121].